IDENTIFICATION OF ANTIBODY TARGETS USING PHOTOACTIVATED CROSS-LINKERS LOCATED IN THE BINDING SITE

Journal Title: World Journal of Pharmaceutical Research - Year 2018, Vol 7, Issue 6

Abstract

We converted the monoclonal antibody (STRO-1), into a recombinant antibody fragment and subsequent alteration of the complementarity determining region (CDR 3) of the variable region of the heavy chain (VH) by site-directed mutagenesis (SDM). We modified the nucleotide codon (TAT) which encode the amino acid tyrosine (Y), to an amber codon (TAG) in DNA or (UAG) in mRNA in the CDR3 of the heavy chain variable region (VH) and was transformed into E.coli (TOP10, XL1-Blue) cells. The amino acid sequence of both the heavy and light chains obtained from US patent no: 8,101,155 B2 (Simmons & Torok- Storb, 1991) were translated to the corresponding nucleotide sequence. The variable region of the heavy chain (VH) and light chain (VL) were amplified by PCR after 30 cycles reaction. However, we were completely unable to clone the native STRO-1 genes that encode for the VH and VL fragments into the pHenIX cloning vector after several attempts. The DNA fragment which contains the sequence that encode the (VH) gene was then cloned into a TA cloning vector (pCR 2.1, 3.9kb) after PCR amplification of the altered target of interest. Following ligation reaction, we transformed E.coli (TOP10) cells, grown overnight, purified, and sequenced for determination of the incorporation of the modified nucleotide sequence. Comparison of the mutated CDR3 of the variable heavy (VH) chain with the native sequence after sequencing was carried out showed that mutation has not occurred at the desired positions due to mismatch of some codons possibly due to incorrect primer design.

Authors and Affiliations

Iyam Solomon Offem

Keywords

Related Articles

QUALITY ANALYSIS OF DIFFERENT MARKETED BRANDS OF ATENOLOL (50 MG) TABLETS AVAILABLE IN SYRIA AND COMPARING WITH THE REFERENCE DRUG

There are numerous generics of atenolol tablets available in Syria. The purpose of current study is to assess the physicochemical characters of four brands(A, B, C, D) of atenolol(50mg) tablets advertised in Syria and co...

BRAHMACHARYA– A CONCEPTUAL ANALYSIS

Ayurveda is one of the ancient knowledge gifted by sages to the mankind, it is not only science of life as well teaches community to lead healthy life style. Ayurveda describes many non pharmacological methods to prevent...

SUSTAINED RELEASE MATRIX TYPE DRUG DELIVERY SYSTEM: REVIEW

Nowadays pharmaceutical industries are aiming on development of sustained release formulations due to its inherent boons. Sustain release system are considered a wiser approach for the drugs with short biological half-li...

ABOUT PREBIOTICS AND PROBIOTICS

In 1899, Henry Tissier, a French pediatrician, isolated a Y-shaped bacterium in the intestinal flora of breast-fed infant, named it “bifidus”. Gram positive anaerobic branching bacteria that has unique ability to ferment...

EVALUATION THE EFFECT OF HYDROFLUORIC ACID AND GRINDING TREATMENT ON SHEAR BOND STRENGTH OF IPS E.MAX PRESS WITH CERAMIC VENEER MATERIAL (AN IN VITRO STUDY)

Back ground: The bond strength is the most common factor success in layer all-ceramic crowns and delaminating is the most common failure reason in the core-veneer interface The core/veneer interface is one of the weakest...

Download PDF file
  • EP ID EP622480
  • DOI -
  • Views 123
  • Downloads 0

How To Cite

Iyam Solomon Offem (2018). IDENTIFICATION OF ANTIBODY TARGETS USING PHOTOACTIVATED CROSS-LINKERS LOCATED IN THE BINDING SITE. World Journal of Pharmaceutical Research, 7(6), 103-117. https://europub.co.uk/articles/-A-622480